Search Medical Condition
Please enter condition
Please choose location from dropdown

Lauderhill, South Carolina Clinical Trials

A listing of Lauderhill, South Carolina clinical trials actively recruiting patient volunteers.

RESULTS

Found (529) clinical trials

EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)

The aim of the study is to investigate the safety and efficacy of empagliflozin versus placebo on top of guideline-directed medical therapy in patients with heart failure with reduced ejection fraction.

Phase

1.21 miles

Learn More »

MILD Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study

Using the Centers for Medicare and Medicaid (CMS) Medicare Research Identifiable Files (RIFs) containing all medical claims for 100% of Medicare beneficiaries enrolled in the Medicare fee-for-service program, claims-based patient history and demographics will be combined with longitudinal analyses. In this study, the control group will include all patients receiving ...

Phase N/A

1.21 miles

Learn More »

Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer

PRIMARY OBJECTIVES: I. To describe the progression-free survival (PFS) of stereotactic body radiation therapy (SBRT) + pembrolizumab (MK-3475) compared to MK-3475 alone in advanced/metastatic merkel cell carcinoma (MCC) patients. SECONDARY OBJECTIVES: I. To describe the PFS of SBRT + MK-3475 compared to MK-3475 alone across Response Evaluation Criteria in Solid ...

Phase

1.21 miles

Learn More »

Safety and Efficacy of TRx0237 in Subjects With Early Alzheimer's Disease

The purpose of this study is to determine the safety and efficacy of TRx0237 8 mg/day and 16 mg/day in the treatment of subjects with early Alzheimer's Disease compared to placebo.

Phase

1.21 miles

Learn More »

A Phase 3 STudy of CaPRe in LOwering Very hiGh TriglYcerides (TRILOGY 2)

The primary objective of this study is to determine the efficacy of CaPre 4 g daily, compared to placebo, in lowering fasting TG levels in subjects with fasting TG levels 500 mg/dL and 1500 mg/dL (5.7 mmol/L and 17.0 mmol/L) after 12 weeks of treatment. Approximately 615 subjects will be ...

Phase

1.21 miles

Learn More »

Durvalumab and Tremelimumab in Treating Patients With Recurrent Stage IV Lung Cancer

PRIMARY OBJECTIVES: I. To evaluate the objective response rate (confirmed and unconfirmed, complete and partial) by Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 among patients treated with durvalumab (MEDI4736) plus tremelimumab. SECONDARY OBJECTIVES: I. To estimate the duration of response (DoR) among patients who achieve a complete response (CR) ...

Phase

1.21 miles

Learn More »

ASBrS NIPPLE SPARING MASTECTOMY REGISTRY Patient selection entails all patients undergoing a Nipple Sparing Mastectomy at the participating institutions who have agreed to participate. All participating patients must complete/sign an informed consent and designated HIPPA form(s).

Phase N/A

1.21 miles

Learn More »

The Neuroform microdelivery stent is a recently developed product that may be of use in treating intracranial wide-necked aneurysms. The Neuroform stent can be placed in a brain artery across the opening of an aneurysm. The coils prevent blood from flowing into the aneurysm and could greatly reduce the risk ...

Phase N/A

1.21 miles

Learn More »

Treatment of diagnosed aneurysm for wide-neck, intracranial, saccular or fusiform aneurysms Patient Inclusion Criteria: Patients diagnosed through 1) CTA (computed tomographic angiography); 2) MRA (magnetic resonance angiography; or 3) diagnostic cerebral angiogram having an aneurysm of qualifying size to require surgical intervention - Coil Embolization Procedure is a type of ...

Phase N/A

1.21 miles

Learn More »

Humanitarian Use Device - Intracranial artery stenosis - The WingspanTM Stent System and GatewayTM PTA Balloon Catheter have been developed for the treatment of intracranial artery stenosis. Patient Inclusion Criteria: Adults > 40 years old with symptomatic stenosis of one of those intracranial arteries: Internal carotid artery (ICA ), M1 ...

Phase N/A

1.21 miles

Learn More »